
26.34 Delayed Data As of Sep 29 | ![]() Today’s Change | 6.64 Today|||52-Week Range 36.36 | +245.67% Year-to-Date |
CHMP Endorses BioMarin's (BMRN) Voxzogo for Use in Infants Sep 18 / Zacks.com - Paid Partner Content | Should You Invest in the SPDR S&P Biotech ETF (XBI)? Sep 18 / Zacks.com - Paid Partner Content |
Previous close | 27.13 |
Today’s open | 27.21 |
Day’s range | 26.07 - 27.29 |
Volume | 48,671 |
Average volume (3 months) | 2,737,252 |
Market cap | $4.4B |
Earnings growth (last year) | +16.27% |
Earnings growth (this year) | +2.99% |
Earnings growth (next 5 years) | -51.17% |
Revenue growth (last year) | +11.38% |
P/E ratio | NM |
Price/Sales | 14.47 |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
IDRSFIdorsia Ltd | +0.09 | +3.33% |
---- | ||
IMMBImmunotech Laborator... | 0.00 | 0.00% |
OASMYVivesto AB | 0.00 | 0.00% |
Next reporting date | November 9, 2023 |
EPS forecast (this quarter) | -$0.77 |
Annual revenue (last year) | $77.6M |
Annual profit (last year) | -$481.2M |
Net profit margin | -619.70% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Palo Alto, California |